D. Pious

发表

Transcriptional regulation of HLA class II and invariant chain genes.

B. Mach, H. Erlich, F. Levine, 1985, Journal of immunology.

Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes

B. Arp, E. Celis, E. Mellins, 1990, Nature.

HLA-DMA and DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells

B. Arp, S. Fling, D. Pious, 1994 .

HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells

B. Arp, S. Fling, D. Pious, 1994, Nature.

Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.

S. Anderson, K. Muczynski, D. Pious, 1998, Journal of immunology.

Novel Mutants Define Genes Required for the Expression of Human Histocompatibility Leukocyte Antigen DM: Evidence for Loci on Human Chromosome 6p

B. Arp, S. Fling, K. Muczynski, 1997, The Journal of experimental medicine.

Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients.

S. Urieli-Shoval, D. Pious, S. Kempin, 1991, Journal of immunology.

HLA-DR Chains Enter into an Aggregated Complex Containing GRP-78/BiP Prior to Their Degradation by the Pre-Golgi Degradative Pathway (*)

D. Pious, T. Cotner, Donald Pious, 1995, The Journal of Biological Chemistry.

Structural analysis of HLA-A2 antigen from immunoselected mutant 8.6.1: further definition of an HLA-A2-specific serological determinant.

J. Strominger, M. Krangel, S. Taketani, 1983, Journal of immunology.

HLA-A2 mutants immunoselected in vitro. Definition of residues contributing to an HLA-A2-specific serological determinant

J. Strominger, M. Krangel, S. Taketani, 1983, The Journal of experimental medicine.

Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.

J. Strominger, C. Ware, M. Krangel, 1983, Journal of immunology.

Production in vitro of murine antibody to a human histocompatibility alloantigen

L. Lampson, F. Grumet, D. Pious, 1978, Nature.

HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants

F. Levine, D. Pious, T. Cotner, 1985, The Journal of experimental medicine.

Human histocompatibility antigen mutants immunoselected in vitro. Biochemical analysis of a mutant which synthesizes an altered HLA-A2 heavy chain.

J. Strominger, M. Krangel, D. Pious, 1982, The Journal of biological chemistry.

Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors

J. Strominger, A. Korman, R. Mulligan, 1987, Molecular and cellular biology.

Gene dosage and gene expression in the HLA region: evidence from deletion variants.

P. Gladstone, D. Pious, L. Fueresz, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Revertants from the HLA class II regulatory mutant 6.1.6: implications for the regulation of Ia gene expression.

F. Levine, D. Pious, 1984, Journal of immunology.

Identification of a trans-acting function regulating HLA-DR expression in a DR-negative B cell variant

P. Gladstone, D. Pious, 1980, Somatic cell genetics.

Isolation and characterization of HL-A variants in cultured human lymphoid cells.

D. Pious, G. Forrest, P. Hawley, 1973, Proceedings of the National Academy of Sciences of the United States of America.

A single amino acid substitution in the human histocompatibility leukocyte antigen DR3 beta chain selectively alters antigen presentation

H. Erlich, B. Arp, E. Mellins, 1988, The Journal of experimental medicine.

Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA- linked control at the effector level

M. Lipinski, W. Fridman, T. Tursz, 1979, The Journal of experimental medicine.

HLA antigen structural gene mutants selected with an allospecific monoclonal antibody.

P. Parham, J. Strominger, M. Krangel, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines.

J. Strominger, B. Zegers, Z. Yang, 1988, The EMBO journal.

Linked marker analysis of spontaneous HLA variants of somatic cells

P. Gladstone, C. Soderland, Susan Martin, 1980, Somatic cell genetics.

Transcription of HLA class II genes in the absence of B-cell-specific octamer-binding factor

D. Pious, E. Stimac, S. Lyons, 1988, Molecular and cellular biology.

Different roles for cytosine methylation in HLA class ii gene expression

F. Levine, D. Pious, 2004, Immunogenetics.

Mapping of the genes encoding the HLA-DR alpha chain and the HLA-related antigens to a chromosome 6 deletion by using genomic blotting.

R. Saiki, H. Erlich, P. Gladstone, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.

J. Mclean, J. Strominger, M. Brenner, 1985, Journal of immunology.

Analysis of the Human Ia Antigens by Gene Cloning

H. Erlich, D. Denney, J. Nunberg, 1983 .

mRNA abundance, rather than differences in subunit assembly, determine differential expression of HLA-DR beta 1 and -DR beta 3 molecules.

H. Charbonneau, E. Mellins, D. Pious, 1989, The Journal of biological chemistry.

Stable variants affecting B cell alloantigens in human lymphoid cells

P. Gladstone, D. Pious, 1978, Nature.

Importance of HLA-DQ and -DP restriction elements in T-cell responses to soluble antigens: mutational analysis.

E. Mellins, M. Woelfel, D. Pious, 1987, Human immunology.

HISTOCOMPATIBILITY LEUKOCYTE ANTIGEN DR3 R CHAIN SELECTIVELY ALTERS ANTIGEN PRESENTATION

H. Erlich, B. Arp, E. Mellins, 1988 .

Antigenic expression and cross reactions in HL-A variants of lymphoid cell lines.

J. Bodmer, W. Bodmer, D. Pious, 2008, Tissue antigens.

Combined Immunodeficiency Caused by a Transactive Regulatory Mutation: A New Mutational Class

D. Pious, 1990 .

Induction of HLA mutations by chemical mutagens in human lymphoid cells

P. Gladstone, C. Soderland, D. Pious, 2005, Immunogenetics.

HLA variants of cultured human lymphoid cells: evidence for mutational origin and estimation of mutation rate.

C. Soderland, D. Pious, 1977, Science.

Absence of DM and Class II Colocalization Nonprofessional Antigen-Presenting Cells with -Induced HLA Class II Proteins in g Discoordinate Surface Expression of IFN-Kimberly

K. Muczynski, S. Anderson, D. Pious, 1998 .

Cyclic AMP in cultured human lymphoid cells: relationship to mitosis.

A. J. Millis, D. Pious, G. Forrest, 1972, Biochemical and biophysical research communications.

Expression of new antigens by HL-A variants of cultured lymphoid cells.

C. Soderland, D. Pious, 1974, Journal of immunology.

Activated Ras Oncogenes Partially Complement the Transcriptional Defects in Class II-Negative Mutant B-Cell Lines

R. Accolla, C. Hume, Janet S. Lee, 1989 .

Immunoselection with HLA-A 2 or HLA-A 1

L., Jack, D. Pious, 2001 .

Mutations affecting antigen processing impair class II-restricted allorecognition.

E. Mellins, A. Johnson, D. Pious, 1991, Journal of immunology.

The molecular basis of HLA cross-reactions: further studies with HLA variants.

P. Gladstone, C. Soderland, D. Pious, 1977, Transplantation proceedings.

Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding

E. Reinherz, L. Clayton, D. Pious, 1989, Nature.

Deletion mapping of HLA and chromosome 6p genes.

B. Mach, H. Erlich, R. White, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Effect of Antibiotics on Respiration in Human Cells

D. Pious, P. Hawley, 1972, Pediatric Research.

Evidence for two trans-acting genes regulating HLA class II antigen expression.

P. Cresswell, F. Levine, R. Salter, 1985, Journal of immunology.

Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.

J. Yates, A. McCormack, D. Pious, 1994, Journal of immunology.

Isoantigenic Variants: Isolation from Human Diploid Cells in Culture

D. Pious, R. Adman, 1970, Science.

Oxidative phosphorylation in mitochondria isolated from human fibroblasts.

A. J. Millis, D. Pious, 1973, Biochimica et biophysica acta.

Cell, Tissue, and Organ Culture as Teratologic Tools

T. Shepard, D. Pious, 1978 .

Genetics of mammalian cell cultures

S. Gartler, D. Pious, 1966, Humangenetik.

ANTIGENIC SPECIFICITIES ACQUIRED FROM THE GROWTH MEDIUM BY CELLS IN TISSUE CULTURE.

D. Pious, R. Hamburger, S. E. Mills, 1963, Immunology.

Colony formation by human fibroblasts: Inhibition by multitransfusion and multiparous antisera

D. Pious, 1968, Biochemical Genetics.

CLONAL GROWTH OF PRIMARY HUMAN CELL CULTURES.

D. Pious, R. Hamburger, S. E. Mills, 1964, Experimental cell research.

Reversible inhibition of cytochrome oxidase accumulation in human cells by ethidium bromide.

D. Pious, Y. Naum, 1971, Experimental cell research.

A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway

R. Demars, T. Spies, E. Mellins, 1990, Nature.

Control of HLA-DR antigen gene expression at the pretranslational level: Comparison of an HLA-DR-positive B lymphoblastoid cell line and its HLA-DR-Negative variant

T. Tamaoki, P. Gladstone, D. Pious, 2004, Immunogenetics.

Mitochondrial enzyme activity in "senescent" and virus-transformed human fibroblasts.

D. Pious, N. Hakami, 1968, Experimental cell research.

A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex

L. Smith, E. Mellins, D. Pious, 1991, The Journal of experimental medicine.

Isolation and Characterization of HLA Variants in Cultured Human Lymphoid Cells

D. Pious, G. Forrest, P. Hawley, 1999 .

Regulation of Cytochrome Oxidase in Human Cells in Culture

D. Pious, N. Hakami, 1967, Nature.

A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides

L. Smith, B. Arp, E. Mellins, 1994, The Journal of experimental medicine.

The firstH- 2 mutant workshop

J. Klein, S. Nathenson, R. Melvold, 1978, Immunogenetics.

Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex.

W. Fiers, C. Morton, J. Strominger, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Twodistinct genetic loci regulating class11gene expression aredefective inhumanmutantandpatient cell lines

D. Pious, 1988 .

Cyclic AMP dependent regulation of mitosis in human lymphoid cells.

A. J. Millis, D. Pious, G. Forrest, 1974, Experimental cell research.

Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells

M. Epstein, A. Rickinson, J. Gaston, 2004, Immunogenetics.

A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. 1990.

R. Demars, S. Bahram, T. Spies, 1991, Journal of immunology.

Characterization of a B lymphoblastoid cell line mutant that secretes HLA-A2.

J. Strominger, M. Krangel, D. Pious, 1984, Journal of Immunology.

The Role of HLA-DM in Class II Antigen Presentation

D. Pious, T. Cotner, 1996 .

Variation in S phase in synchronous human cell lines

L. Kapp, A. J. Millis, D. Pious, 1979, In Vitro.

Induction of Cytochromes in Human Cells by Oxygen

D. Pious, 1970 .

Exogenously provided peptides fail to complex with intracellular class II molecules for presentation by antigen-presenting cells.

D. Pious, T. Monji, 1997, Journal of Immunology.

Characterization of Multiple HLA-DR3 Haplotypes

E. Mellins, D. Pious, T. Cotner, 1989 .

Induction of HLA mutations by chemical mutagens in human lymphoid cells

P. Gladstone, C. Soderland, D. Pious, 1977, Immunogenetics.

Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.

B. Arp, B. Carreno, E. Mellins, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Novel Mutants Define Genes Required for the Expression of Human Histocompatibility Leukocyte Antigen DM: Evidence for Loci on Human Chromosome 6p

B. Arp, S. Fling, K. Muczynski, 1997, The Journal of experimental medicine.

Killing of Cultured Rabbit Fibroblasts with Isoimmune Serum

S. Mills, D. Pious, 1963, Science.